Abstract
Continuous positive airway pressure (CPAP) is increasingly used in infants. However, the limited number of commercially masks available for infants is challenging. The use of the Optiflow™ nasal cannula (Fisher & Paykel) with a regular CPAP device has been recently reported for chronic CPAP in children, with an objective improvement in polysomnographic events. However, this interface has not been used in young infants. We report here our experience of 4 infants aged between 3 and 8 weeks, who were treating with home CPAP with the Optiflow™ nasal cannula during a few months, before they could be successfully weaned. This pilot study reinforces the findings of the beneficial use of nasal cannula in very young infants in whom nasal masks are scarce and not always suitably adapted. However, as this interface is not intended to be used with home CPAP, further studies are necessary to prove its clinical benefice and safety of use with home CPAP devices.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: Sleep Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
